SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-030304
Filing Date
2019-05-17
Accepted
2019-05-17 16:40:03
Documents
3
Period of Report
2019-05-17
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-10174_18k.htm 8-K 39722
2 EX-1.1 a19-10174_1ex1d1.htm EX-1.1 269518
3 EX-5.1 a19-10174_1ex5d1.htm EX-5.1 7769
  Complete submission text file 0001104659-19-030304.txt   318266
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36020 | Film No.: 19836364
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1